Stockscreener 앱 받기
19.94
3.25%
-0.67
전일 마감가:
$20.61
열려 있는:
$20.3
하루 거래량:
92,820
Relative Volume:
1.35
시가총액:
$171.37M
수익:
$44.05M
순이익/손실:
$11.81M
주가수익비율:
-117.57
EPS:
-0.1696
순현금흐름:
$1.93M
1주 성능:
+15.73%
1개월 성능:
-1.29%
6개월 성능:
-36.29%
1년 성능:
-33.49%
1일 변동 폭
$19.39
$20.75
1주일 범위
$17.19
$21.17
52주 변동 폭
$16.27
$46.59
Sanuwave Health Inc Stock (SNWV) Company Profile
명칭
Sanuwave Health Inc
전화
952-656-1029
주소
9600 W. 6TH SSTREET, EDEN PRAIRIE
Compare SNWV vs GOODO, SHMD, PSNYW, DWLD, QQQE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNWV
Sanuwave Health Inc
|
29.00 | 34.02M | 0 | 0 | 0 | 0.00 |
GOODO
Gladstone Commercial Corporation
|
19.96 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
6.46 | 383.66M | 52.15M | -21.46M | 0 | -0.4675 |
PSNYW
Polestar Automotive Holding Uk
|
3.1001 | 320.99M | 2.07B | -1.42B | -1.37B | -0.6765 |
DWLD
Davis Select Worldwide ETF
|
46.87 | 0 | 0 | 0 | 0 | 0.00 |
QQQE
Direxion NASDAQ-100 Equal Weigh
|
107.08 | 0 | 0 | 0 | 0 | 0.00 |
Sanuwave Health Inc Stock (SNWV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 개시 | Northland Capital | Outperform |
| 2025-07-29 | 개시 | Roth Capital | Buy |
Sanuwave Health Inc 주식(SNWV)의 최신 뉴스
Sanuwave Health (SNWV) Slipped as CMS Dropped the Coverage Limit - Insider Monkey
Sanuwave Health preliminary revenue up 3-4% in Q1 2026 - Medical Buyer
SANUWAVE Health | 8-K: Current report - Moomoo
SNWV Forecast, Price Target & Analyst Ratings | SANUWAVE HEALTH INC (NASDAQ:SNWV) - ChartMill
SNWV: Q1 Revenues Reflect Wound Care Market Adjustments - GuruFocus
Sanuwave reports Q1 revenue of $9.6M-$9.7M, up 3-4% year-over-year By Investing.com - Investing.com South Africa
Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year - Ortho Spine News
Sanuwave reports Q1 revenue of $9.6M-$9.7M, up 3-4% year-over-year - Investing.com
Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6-$9.7 Million, Up 3-4% Year-over-Year - The Manila Times
Sanuwave (NASDAQ: SNWV) sees Q1 2026 revenue at $9.6–$9.7M - Stock Titan
Sanuwave Health reports preliminary Q1 2026 revenue of $9.6-$9.7 million, up 3-4% Year-over-year - marketscreener.com
Reimbursement shifts shake wound care; Sanuwave Q1 sales near $9.7M - Stock Titan
Aug Opening: Can SANUWAVE Health Inc deliver consistent dividends2026 Outlook & Reliable Trade Execution Plans - baoquankhu1.vn
Aug Big Picture: How liquid is SANUWAVE Health Inc stockWeekly Stock Summary & AI Driven Price Predictions - baoquankhu1.vn
How The SANUWAVE Health (SNWV) Investment Narrative Is Resetting After A Lower Price Target - Yahoo Finance
SANUWAVE Health Inc (SNWV) Shares Fall 7.2% -- GF Value Says Still Overvalued - GuruFocus
Aug Mood: Is SANUWAVE Health Inc likely to announce a buybackJobs Report & Consistent Profit Trade Alerts - baoquankhu1.vn
Travel Stocks: Why is SANUWAVE Health Inc stock going downTrade Exit Report & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Sanuwave Health Q4 2025 Earnings Call Transcript - MarketBeat
Update Recap: Is SANUWAVE Health Inc being accumulated by smart moneyQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
Head to Head Survey: Sanuwave Health (NASDAQ:SNWV) and INLIF (NASDAQ:INLF) - Defense World
SANUWAVE Health Inc (SNWV) Stock Price Up 1.48% on Apr 6 - GuruFocus
Setup Watch: Is SANUWAVE Health Inc stock undervalued right now2026 Sector Moves & AI Based Trade Execution Alerts - baoquankhu1.vn
Macro Review: Can SANUWAVE Health Inc generate free cash flow2026 Movers & Weekly High Return Forecasts - baoquankhu1.vn
Sanuwave Health Posts Record Results Amid CMS Shock - TipRanks
SNWV SEC FilingsSanuwave Health 10-K, 10-Q, 8-K Forms - Stock Titan
Director Tyler James granted 3,208 SANUWAVE (SNWV) stock options at $17.29 - Stock Titan
SANUWAVE Health (SNVW) CEO Frank Morgan awarded 3,208 stock options - Stock Titan
[Form 4] SANUWAVE Health, Inc. Insider Trading Activity - Stock Titan
Director at SANUWAVE Health (SNVW) gets 3,208 fully vested options - Stock Titan
Sanuwave Health (NASDAQ:SNWV) Rating Lowered to "Strong Sell" at Zacks Research - MarketBeat
Sanuwave Health (NASDAQ:SNWV) Given “Buy” Rating at Roth Mkm - Defense World
Sanuwave Health (SNWV) Projected to Post Earnings on Tuesday - MarketBeat
SNWV Sees Updated Analyst Rating: Roth Capital Lowers Price Targ - GuruFocus
Roth Mkm Reiterates "Buy" Rating for Sanuwave Health (NASDAQ:SNWV) - MarketBeat
SANUWAVE outlines 16–25% revenue growth target for 2026 as reseller expansion accelerates - MSN
Aug Levels: What drives SANUWAVE Health Incs stock priceWeekly Stock Recap & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
How The Reset Price Target Is Rewriting The Story For SANUWAVE Health (SNWV) - Yahoo Finance
Sanuwave Health Q4 Earnings Call Highlights - Defense World
SANUWAVE Health, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
SANUWAVE Q4 2025 slides: record revenue, stock tumbles on concerns By Investing.com - Investing.com Australia
Sanuwave Health (NASDAQ:SNWV) Downgraded by Wall Street Zen to Hold - MarketBeat
SANUWAVE Health Hits 52-Week Low at $18.61 Amid Market Volatility - Markets Mojo
Vanguard disaggregates holdings in SANUWAVE (NASDAQ: SNWV) — 0% reported - Stock Titan
Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025 - Ortho Spine News
Death Cross: Why is SANUWAVE Health Inc stock going down2026 Stock Rankings & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Earnings call transcript: SANUWAVE’s Q4 2025 revenue hits record, stock dips premarket - Investing.com Australia
SANUWAVE Q4 2025 slides: record revenue, stock tumbles on concerns - Investing.com India
Earnings call transcript: SANUWAVE’s Q4 2025 revenue hits record, stock dips premarket By Investing.com - Investing.com South Africa
SNWV: Record revenue and EBITDA growth achieved amid industry disruption and strategic channel expansion - TradingView
SANUWAVE Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView — Track All Markets
Sanuwave Health Inc (SNWV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.74%
1.72%
자본화:
|
볼륨(24시간):